Better Coronavirus Stock: Moderna vs. Sorrento Therapeutics

Better Coronavirus Stock: Moderna vs. Sorrento Therapeutics

As a result, investors have begun panic-buying biotech companies on the frontiers of creating new treatments and vaccines for COVID-19. In another article, I discussed how the company made some glaring statements regarding the effectiveness of its antibodies on Fox News. Here, we will focus on what Sorrento is doing in other significant areas to fight the pandemic.